155 related articles for article (PubMed ID: 33307392)
1. Impact of body mass index on overall survival in patients with metastatic breast cancer.
Saleh K; Carton M; Dieras V; Heudel PE; Brain E; D'Hondt V; Mailliez A; Patsouris A; Mouret-Reynier MA; Goncalves A; Ferrero JM; Petit T; Emile G; Uwer L; Debled M; Dalenc F; Jouannaud C; Ladoire S; Leheurteur M; Cottu P; Veron L; Savignoni A; Courtinard C; Robain M; Delaloge S; Deluche E
Breast; 2021 Feb; 55():16-24. PubMed ID: 33307392
[TBL] [Abstract][Full Text] [Related]
2. The prognostic impact of BMI in patients with HR+/HER2- advanced breast cancer: a study of the SONABRE registry.
Lammers SWM; Thurisch H; Vriens IJH; Meegdes M; Engelen SME; Erdkamp FLG; Dercksen MW; Vriens BEPJ; Aaldering KNA; Pepels MJAE; van de Winkel LMH; Peters NAJB; Tol J; Heijns JB; van de Wouw AJ; Teeuwen NJA; Geurts SME; Tjan-Heijnen VCG
Breast Cancer Res Treat; 2024 Jan; 203(2):339-349. PubMed ID: 37878148
[TBL] [Abstract][Full Text] [Related]
3. Impact of body mass index on the clinical outcomes of patients with HER2-positive metastatic breast cancer.
Martel S; Poletto E; Ferreira AR; Lambertini M; Sottotetti F; Bertolini I; Montemurro F; Bernardo A; Risi E; Zanardi E; Ziliani S; Mura S; Dellepiane C; Del Mastro L; Minisini AM; Puglisi F
Breast; 2018 Feb; 37():142-147. PubMed ID: 29161652
[TBL] [Abstract][Full Text] [Related]
4. [Body mass index and cancer incidence:a prospective cohort study in northern China].
Guo L; Li N; Wang G; Su K; Li F; Yang L; Ren J; Chang S; Chen S; Wu S; He J; Dai M
Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Mar; 35(3):231-6. PubMed ID: 24831616
[TBL] [Abstract][Full Text] [Related]
5. First-line real-world treatment patterns and survival outcomes in women younger or older than 40 years with metastatic breast cancer in the real-life multicenter French ESME cohort.
Galvin A; Courtinard C; Bouteiller F; Gourgou S; Dalenc F; Jacot W; Arnedos M; Bailleux C; Dieras V; Petit T; Emile G; Dubray-Longeras P; Frenel JS; Bachelot T; Mailliez A; Brain E; Desmoulins I; Massard V; Patsouris A; Goncalves A; Grinda T; Delaloge S; Bellera C
Eur J Cancer; 2024 Jan; 196():113422. PubMed ID: 37977105
[TBL] [Abstract][Full Text] [Related]
6. The impact of baseline body mass index on clinical outcomes in metastatic breast cancer: a prospective study.
Alarfi H; Salamoon M; Kadri M; Alammar M; Haykal MA; Alseoudi A; Youssef LA
BMC Res Notes; 2017 Nov; 10(1):550. PubMed ID: 29096707
[TBL] [Abstract][Full Text] [Related]
7. Contemporary outcomes of metastatic breast cancer among 22,000 women from the multicentre ESME cohort 2008-2016.
Deluche E; Antoine A; Bachelot T; Lardy-Cleaud A; Dieras V; Brain E; Debled M; Jacot W; Mouret-Reynier MA; Goncalves A; Dalenc F; Patsouris A; Ferrero JM; Levy C; Lorgis V; Vanlemmens L; Lefeuvre-Plesse C; Mathoulin-Pelissier S; Petit T; Uwer L; Jouannaud C; Leheurteur M; Lacroix-Triki M; Courtinard C; Perol D; Robain M; Delaloge S
Eur J Cancer; 2020 Apr; 129():60-70. PubMed ID: 32135312
[TBL] [Abstract][Full Text] [Related]
8. Effect of body mass index on survival of patients with stage I non-small cell lung cancer.
Xie HJ; Zhang X; Wei ZQ; Long H; Rong TH; Su XD
Chin J Cancer; 2017 Jan; 36(1):7. PubMed ID: 28069048
[TBL] [Abstract][Full Text] [Related]
9. Body mass index and prognosis of metastatic breast cancer patients receiving first-line chemotherapy.
Gennari A; Nanni O; Puntoni M; DeCensi A; Scarpi E; Conte P; Antonucci G; Amadori D; Bruzzi P
Cancer Epidemiol Biomarkers Prev; 2013 Oct; 22(10):1862-7. PubMed ID: 23945199
[TBL] [Abstract][Full Text] [Related]
10. Impact of body mass index on clinical outcomes in triple-negative breast cancer.
Ademuyiwa FO; Groman A; O'Connor T; Ambrosone C; Watroba N; Edge SB
Cancer; 2011 Sep; 117(18):4132-40. PubMed ID: 21387276
[TBL] [Abstract][Full Text] [Related]
11. Time trends of overall survival among metastatic breast cancer patients in the real-life ESME cohort.
Gobbini E; Ezzalfani M; Dieras V; Bachelot T; Brain E; Debled M; Jacot W; Mouret-Reynier MA; Goncalves A; Dalenc F; Patsouris A; Ferrero JM; Levy C; Lorgis V; Vanlemmens L; Lefeuvre-Plesse C; Mathoulin-Pelissier S; Petit T; Uwer L; Jouannaud C; Leheurteur M; Lacroix-Triki M; Cleaud AL; Robain M; Courtinard C; Cailliot C; Perol D; Delaloge S
Eur J Cancer; 2018 Jun; 96():17-24. PubMed ID: 29660596
[TBL] [Abstract][Full Text] [Related]
12. Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence.
Krasniqi E; Pizzuti L; Barchiesi G; Sergi D; Carpano S; Botti C; Kayal R; Sanguineti G; Marchetti P; Botticelli A; Marinelli D; Gamucci T; Natoli C; Grassadonia A; Tinari N; Tomao S; Tonini G; Santini D; Michelotti A; Mentuccia L; Vaccaro A; Magnolfi E; Gelibter A; Magri V; Cortesi E; D'Onofrio L; Cassano A; Cazzaniga M; Moscetti L; Fabbri A; Scinto AF; Corsi D; Carbognin L; Bria E; La Verde N; Garufi C; Di Stefano P; Mirabelli R; Veltri E; Paris I; Giotta F; Lorusso V; Landucci E; Ficorella C; Roselli M; Adamo V; Ricciardi G; Russo A; Valerio MR; Berardi R; Pistelli M; Cannita K; Zamagni C; Garrone O; Baldini E; Livi L; Meattini I; Del Medico P; Generali D; De Maria R; Risi E; Ciliberto G; Villa A; Sperduti I; Mazzotta M; Barba M; Giordano A; Vici P
J Cell Physiol; 2020 Nov; 235(11):7900-7910. PubMed ID: 31943171
[TBL] [Abstract][Full Text] [Related]
13. Obesity and breast cancer outcomes in chemotherapy patients in New Zealand - a population-based cohort study.
Elwood JM; Tin Tin S; Kuper-Hommel M; Lawrenson R; Campbell I
BMC Cancer; 2018 Jan; 18(1):76. PubMed ID: 29334917
[TBL] [Abstract][Full Text] [Related]
14. Overweight/obese status associates with favorable outcome in patients with metastatic nasopharyngeal carcinoma: a 10-year retrospective study.
Li W; Shen LJ; Chen T; Sun XQ; Zhang Y; Wu M; Shu WH; Chen C; Pan CC; Xia YF; Wu PH
Chin J Cancer; 2016 Aug; 35(1):75. PubMed ID: 27507261
[TBL] [Abstract][Full Text] [Related]
15. Obesity as an independent risk factor for decreased survival in node-positive high-risk breast cancer.
Scholz C; Andergassen U; Hepp P; Schindlbeck C; Friedl TW; Harbeck N; Kiechle M; Sommer H; Hauner H; Friese K; Rack B; Janni W
Breast Cancer Res Treat; 2015 Jun; 151(3):569-76. PubMed ID: 25962694
[TBL] [Abstract][Full Text] [Related]
16. Obesity is an independent prognostic factor of decreased pathological complete response to neoadjuvant chemotherapy in breast cancer patients.
Karatas F; Erdem GU; Sahin S; Aytekin A; Yuce D; Sever AR; Babacan T; Ates O; Ozisik Y; Altundag K
Breast; 2017 Apr; 32():237-244. PubMed ID: 27318645
[TBL] [Abstract][Full Text] [Related]
17. Body mass index and prognosis of breast cancer: An analysis by menstruation status when breast cancer diagnosis.
Sun L; Zhu Y; Qian Q; Tang L
Medicine (Baltimore); 2018 Jun; 97(26):e11220. PubMed ID: 29952978
[TBL] [Abstract][Full Text] [Related]
18. Impact of BMI for clinical outcomes in Japanese breast cancer patients.
Gondo N; Sawaki M; Hattori M; Yoshimura A; Kotani H; Adachi Y; Kataoka A; Sugino K; Mori M; Horisawa N; Terada M; Ozaki Y; Iwata H
Jpn J Clin Oncol; 2020 Mar; 50(3):230-240. PubMed ID: 31958129
[TBL] [Abstract][Full Text] [Related]
19. Early Locoregional Breast Surgery and Survival in de novo Metastatic Breast Cancer in the Multicenter National ESME Cohort.
Hotton J; Lusque A; Leufflen L; Campone M; Levy C; Honart JF; Mailliez A; Debled M; Gutowski M; Leheurteur M; Goncalves A; Jankowski C; Guillermet S; Bachelot T; Ferrero JM; Eymard JC; Petit T; Pouget N; de La Lande B; Frenel JS; Villacroux O; Simon G; Pons-Tostivint E; Marchai F
Ann Surg; 2023 Jan; 277(1):e153-e161. PubMed ID: 33534229
[TBL] [Abstract][Full Text] [Related]
20. Overweight, Obesity, and Postmenopausal Invasive Breast Cancer Risk: A Secondary Analysis of the Women's Health Initiative Randomized Clinical Trials.
Neuhouser ML; Aragaki AK; Prentice RL; Manson JE; Chlebowski R; Carty CL; Ochs-Balcom HM; Thomson CA; Caan BJ; Tinker LF; Urrutia RP; Knudtson J; Anderson GL
JAMA Oncol; 2015 Aug; 1(5):611-21. PubMed ID: 26182172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
